Intellipharmaceutics inc
NettetIntelliPharmaCeutics International Inc. develops drug delivery technologies. The Company has developed a controlled release drug delivery platform to provide life cycle … Nettet如果您是机构，请点击下方了解我们为ria、对冲基金、合规官员等提供的服务。
Intellipharmaceutics inc
Did you know?
Nettet14. apr. 2024 · Intellipharmaceutics International Inc. a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three months ended February 28, 2024. NettetIntelliPharmaCeutics Intl Inc (IPCIF) Stock Price & News - Google Finance +$0.65 Home IPCIF • OTCMKTS IntelliPharmaCeutics Intl Inc Follow Share $0.075 Feb 3, 8:10:00 PM GMT-5 · USD ·...
Nettet2. jul. 2024 · Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral... NettetAt Intellipharmaceutics, we are engaged in the research, development and commercialization of pharmaceutical products, both novel and generic, with a particular …
Nettet6. jun. 2024 · Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral ... NettetGet the latest IntelliPharmaCeutics Intl Inc (IPCI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
NettetPLACEMENT AGENT COMMON STOCK PURCHASE WARRANT INTELLIPHARMACEUTICS INTERNATIONAL INC. Document Metadata. Filed: March 20th, 2024. Industry Pharmaceutical preparations; Company Intellipharmaceutics International Inc. SEC Filing ID 0001654954-18-002788; SEC Filing Type 6-k; SEC …
NettetIntelliPharmaCeutics Intl Inc (IPCIF) Stock Price & News - Google Finance +$0.65 Home IPCIF • OTCMKTS IntelliPharmaCeutics Intl Inc Follow Share $0.075 Feb 3, 8:10:00 … svo groupNettet1. mar. 2024 · TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCIF) on Monday reported a loss of $2 million in its fiscal fourth quarter. The Toronto-based company said it had a loss of 17 cents per share. For the year, the company reported that its loss widened to $5.1 million, or 17 cents per share. _____ svo group reviewNettet6. apr. 2024 · Short selling IPCIF is an investing strategy that aims to generate trading profit from Intellipharmaceutics International as its price is falling. To short a stock, an … sv og rostockNettetIntellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in … svo group sdn bhdNettet8. feb. 2024 · Intellipharmaceutics Signs an Exclusive License & Supply Agreement with Taro Pharmaceuticals Inc. for Desvenlafaxine Extended-Release Tablets. … svog sba.govNettetIntellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in … svo group incNettet30. nov. 2024 · Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic … baseballer hideki